KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $16.9 billion.

  • Bristol Myers Squibb's Retained Earnings rose 1330.47% to $16.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.9 billion, marking a year-over-year increase of 1330.47%. This contributed to the annual value of $16.9 billion for FY2025, which is 1330.47% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Retained Earnings stood at $16.9 billion, which was up 1330.47% from $17.1 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Retained Earnings peaked at $28.8 billion during Q4 2023, and registered a low of $14.9 billion during Q4 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Retained Earnings value was $22.4 billion (recorded in 2021), while the average stood at $21.5 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 1435.87% in 2023, then tumbled by 4816.1% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Retained Earnings stood at $23.8 billion in 2021, then rose by 7.07% to $25.5 billion in 2022, then increased by 12.79% to $28.8 billion in 2023, then crashed by 48.16% to $14.9 billion in 2024, then rose by 13.3% to $16.9 billion in 2025.
  • Its Retained Earnings was $16.9 billion in Q4 2025, compared to $17.1 billion in Q3 2025 and $16.2 billion in Q2 2025.